Award recordCONTRACT

ROCHE DIAGNOSTICS CORPORATION

PIID VA24713F2351· VHA· 247-NETWORK CONTRACT OFFICE 7 (36C247)· 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS· FY2013· $2,412,834 net obligations· UEI JDMDFEZBYH36· IN

Description

CHEMISTRY AND IMMUNOCHEMISTRY ANALYZER IGF::CT::IGF INCREASE OF FUNDS (557-C65116).

Base award description: CHEMISTRY AND IMMUNOCHEMISTRY ANALYZER

First action · last action
2013-08-27 · 2018-12-01
Transactions
12
First transaction's obligation
$504,916
Base + all options value (sum of deltas)
$3,956,982
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
5
SDVOSB flag on record
No
Parent IDV
V797P7347A
NAICS
334516 · ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING

Modification chain · 12 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$2,412,834$0Base award · 2013-08-27 · this action $504,916 · running total $504,916Modification P00001 · 2014-01-16 · this action $4,665 · running total $509,581Modification P00002 · 2014-06-17 · this action $509,581 · running total $1,019,162Modification P00003 · 2014-12-09 · this action -$133,395 · running total $885,767Modification P00004 · 2015-07-21 · this action $509,581 · running total $1,395,348Modification P00005 · 2016-01-07 · this action -$20,070 · running total $1,375,277Modification P00006 · 2016-03-07 · this action $144,000 · running total $1,519,277Modification P00007 · 2016-07-19 · this action $653,581 · running total $2,172,858Modification P00008 · 2016-11-21 · this action -$420,735 · running total $1,752,123Modification P00009 · 2017-07-19 · this action $653,581 · running total $2,405,704Modification P00010 · 2017-10-23 · this action $2,607 · running total $2,408,312Modification P00011 · 2018-12-01 · this action $4,523 · running total $2,412,834
  • Base2013-08-27+$504,916= $504,916
  • Mod P000012014-01-16+$4,665= $509,581
  • Mod P000022014-06-17+$509,581= $1,019,162
  • Mod P000032014-12-09-$133,395= $885,767
  • Mod P000042015-07-21+$509,581= $1,395,348
  • Mod P000052016-01-07-$20,070= $1,375,277
  • Mod P000062016-03-07+$144,000= $1,519,277
  • Mod P000072016-07-19+$653,581= $2,172,858
  • Mod P000082016-11-21-$420,735= $1,752,123
  • Mod P000092017-07-19+$653,581= $2,405,704
  • Mod P000102017-10-23+$2,607= $2,408,312
  • Mod P000112018-12-01+$4,523= $2,412,834
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2013-08-27+$504,916$504,916CHEMISTRY AND IMMUNOCHEMISTRY ANALYZER
Mod P00001· CHANGE ORDER2014-01-16+$4,665$509,581CHEMISTRY AND IMMUNOCHEMISTRY ANALYZER IGF::CT::IGF
Mod P00002· EXERCISE AN OPTION2014-06-17+$509,581$1,019,162CHEMISTRY AND IMMUNOCHEMISTRY ANALYZER IGF::CT::IGF
Mod P00003· FUNDING ONLY ACTION2014-12-09−$133,395$885,767CHEMISTRY AND IMMUNOCHEMISTRY ANALYZER IGF::CT::IGF DE-OBLIGATION OF FUNDS (557-C35186).
Mod P00004· EXERCISE AN OPTION2015-07-21+$509,581$1,395,348CHEMISTRY AND IMMUNOCHEMISTRY ANALYZER IGF::CT::IGF DE-OBLIGATION OF FUNDS (557-C35186).
Mod P00005· FUNDING ONLY ACTION2016-01-07−$20,070$1,375,277CHEMISTRY AND IMMUNOCHEMISTRY ANALYZER IGF::CT::IGF DE-OBLIGATION OF FUNDS (557-C35186).
Mod P00006· FUNDING ONLY ACTION2016-03-07+$144,000$1,519,277CHEMISTRY AND IMMUNOCHEMISTRY ANALYZER IGF::CT::IGF DE-OBLIGATION OF FUNDS (557-C35186).
Mod P00007· EXERCISE AN OPTION2016-07-19+$653,581$2,172,858CHEMISTRY AND IMMUNOCHEMISTRY ANALYZER IGF::CT::IGF DE-OBLIGATION OF FUNDS (557-C35186).
Mod P00008· EXERCISE AN OPTION2016-11-21−$420,735$1,752,123CHEMISTRY AND IMMUNOCHEMISTRY ANALYZER IGF::CT::IGF DE-OBLIGATION OF FUNDS (557-C35186).
Mod P00009· EXERCISE AN OPTION2017-07-19+$653,581$2,405,704CHEMISTRY AND IMMUNOCHEMISTRY ANALYZER IGF::CT::IGF DE-OBLIGATION OF FUNDS (557-C35186).
Mod P00010· CHANGE ORDER2017-10-23+$2,607$2,408,312CHEMISTRY AND IMMUNOCHEMISTRY ANALYZER IGF::CT::IGF INCREASE OF FUNDS (557-C65116).
Mod P00011· CHANGE ORDER2018-12-01+$4,523$2,412,834CHEMISTRY AND IMMUNOCHEMISTRY ANALYZER IGF::CT::IGF INCREASE OF FUNDS (557-C65116).

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI JDMDFEZBYH36)

AwardOffice · PSC / listingNet obligationsFY
36C25026N0794250-NETWORK CONTRACT OFFICE 10 (36C250) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$200,000FY2026
36C25026N0788250-NETWORK CONTRACT OFFICE 10 (36C250) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$135,282FY2026
36C25726N0474257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$21,384FY2026
36C25726C0089257-NETWORK CONTRACT OFFICE 17 (36C257) · J066 · MAINT/REPAIR/REBUILD OF EQUIPMENT- INSTRUMENTS AND LABORATORY EQUIPMENT$46,948FY2026
36C25926N0437NETWORK CONTRACT OFFICE 19 (36C259) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES$35,030FY2026
36C25926N0438NETWORK CONTRACT OFFICE 19 (36C259) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES$34,878FY2026

Other recipients under 6550 from 247-NETWORK CONTRACT OFFICE 7 (36C247) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C24726P0530FIRST NATION GROUP LLC247-NETWORK CONTRACT OFFICE 7 (36C247)$146,995FY2026
36C24726P0296CEPHEID247-NETWORK CONTRACT OFFICE 7 (36C247)$179,700FY2026
36C24725F0318QUIDELORTHO SALES COMPANY, LLC247-NETWORK CONTRACT OFFICE 7 (36C247)$294,875FY2025
36C24725P0739MAXCYTE, INC.247-NETWORK CONTRACT OFFICE 7 (36C247)$49,680FY2025
36C24725P0048POLYMEDCO LLC247-NETWORK CONTRACT OFFICE 7 (36C247)$1,936,200FY2025

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24713F2351_3600_V797P7347A_3600 · retrieved 2026-09-26.